Jeffery W. Kelly

Prix

1. 2022

   Prix Breakthrough — Sciences de la vie

   Biologie

   for elucidating the molecular basis of neurodegenerative and cardiac transthyretin diseases, and for developing tafamidis, a drug that slows their progression.

2. 2023

   Prix Wolf — Chimie

   Chimie

   for developing a clinical strategy to ameliorate pathological protein aggregation.

3. 2026

   Prix international Canada Gairdner

   Biologie

   For discovering the anti-aggregation drug, tafamidis, the first effective treatment for a human amyloid disease, specifically transthyretin amyloidosis, providing the first pharmacological evidence that protein aggregation drives neurodegeneration.